The psychotherapy in MDMA-assisted psychotherapy

This excellent article discusses the psychotherapy component of MDMA-assisted treatment for PTSD. The authors wriite: "On June 4, 2024, the Psychopharmacologic Drugs Advisory Committee for the Food and Drug Administration (FDA) overwhelmingly voted that the efficacy of midomafetamine/3,4-methylenedioxymethamphetamine (MDMA)–assisted psychotherapy for posttraumatic stress disorder (PTSD) was yet unsupported and that safety risks outweighed the treatment benefits. On August 9, 2024, the FDA followed the recommendation of the Advisory Committee and declined to approve MDMA-assisted psychotherapy. The intervention (for PTSD) is composite, and its outcomes assumed to result from MDMA facilitating the effects of psychotherapy. In this Viewpoint, we argue that the psychotherapy component plays a critical role in assessing the validity of the trials." You may find that the full text is behind a paywall for you. If so, you can try requesting a free copy from the authors via Researchgate.

For more psychedelic news and research, visit the psychedelic health professional network homepage.